Now don’t get me wrong, I am the FIRST person who is appreciative of any efforts to help restore my sight. Personally though, ...

Elon Musk’s brain implant company Neuralink is planning to raise about $500 million at a valuation of $8.5 billion.

Howie and Harlan welcome Evan Sussman, the CEO of Granata Bio, which aims to bring IVF and fertility drugs that have been proven in other markets to the United States. Harlan reports on Elon Musk’s ...

Elon Musk ‘Blindsight’ chip Implant: Elon Musk said his brain chip startup Neuralink aims to have its artificial visual prosthesis, Blindsight, implanted in a human for the first time by the end of ...

Neuralink's Blindsight chip, set for human trials in 2025, aims to restore vision for the blind. Elon Musk's brain-chip company, Neuralink, plans to implant its innovative Blindsight chip into a human ...

Elon Musk’s Neuralink to implant its Blindsight chip in first human in 2025 The chip is aimed to restore vision even in people who have lost both eyes The Blindsight chip received US FDA approval in ...

Elon Musk’s brain chip company, Neuralink, is aiming to achieve a major medical milestone by the end of 2025 with the first human implantation of its artificial visual prosthesis, Blindsight.

And his Neuralink start-up has received FDA breakthrough device designation for Blindsight, an experimental implant aimed at restoring vision in individuals who have lost sight in both eyes.

Blindsight, an artificial intelligence (AI)-driven vision safety solution from technology solutions provider Aptella, has been named joint winner of the Queensland Major Contractors Association (QMCA) ...